Clinical Trial

HRQoL and Financial Toxicity in Patients With VEXAS Syndrome

Name: HRQoL and Financial Toxicity in Patients With VEXAS Syndrome — clinical trial record (NCT06657846)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This multicenter cross-sectional observational study aims to describe health-related quality of life (HRQoL) and symptom profiles of patients with VEXAS syndrome.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-10-23.

Status change: Not Yet Recruiting → Recruiting 2025-07-14

Trial Details

NCT Number	NCT06657846
Lead Sponsor	Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions	VEXAS
Enrollment	100 participants
Start Date	2024-11-01
Primary Completion	2025-06-10 (estimated)
Study Completion	2025-09-10 (estimated)
Updated on ClinicalTrials.gov	2025-07-15